IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.805
AS - Asia 19.747
EU - Europa 16.630
SA - Sud America 4.480
AF - Africa 532
Continente sconosciuto - Info sul continente non disponibili 499
OC - Oceania 50
Totale 74.743
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.235
SG - Singapore 7.161
RU - Federazione Russa 4.958
CN - Cina 4.884
IT - Italia 4.840
BR - Brasile 3.479
VN - Vietnam 2.594
GB - Regno Unito 1.784
HK - Hong Kong 1.412
BD - Bangladesh 1.391
DE - Germania 1.119
CA - Canada 999
FR - Francia 662
FI - Finlandia 537
SE - Svezia 504
IN - India 480
UA - Ucraina 472
IE - Irlanda 456
AR - Argentina 354
MX - Messico 334
NL - Olanda 291
TR - Turchia 291
PL - Polonia 253
ID - Indonesia 231
ES - Italia 198
ZA - Sudafrica 195
EC - Ecuador 184
IQ - Iraq 182
JP - Giappone 173
IL - Israele 171
PK - Pakistan 156
CO - Colombia 123
AT - Austria 108
VE - Venezuela 98
MA - Marocco 86
AE - Emirati Arabi Uniti 82
UZ - Uzbekistan 76
DK - Danimarca 72
LT - Lituania 66
PY - Paraguay 63
CL - Cile 61
EG - Egitto 58
MY - Malesia 56
SA - Arabia Saudita 56
PE - Perù 46
TN - Tunisia 46
KE - Kenya 44
CH - Svizzera 43
CR - Costa Rica 41
PH - Filippine 40
BE - Belgio 37
AU - Australia 32
UY - Uruguay 32
JO - Giordania 31
AZ - Azerbaigian 30
BO - Bolivia 30
JM - Giamaica 30
DZ - Algeria 29
RO - Romania 25
GT - Guatemala 24
HN - Honduras 24
CZ - Repubblica Ceca 23
NP - Nepal 23
KZ - Kazakistan 22
DO - Repubblica Dominicana 21
TH - Thailandia 21
OM - Oman 19
PT - Portogallo 19
EU - Europa 17
IR - Iran 17
AL - Albania 16
SK - Slovacchia (Repubblica Slovacca) 16
TW - Taiwan 16
KR - Corea 15
LB - Libano 15
NI - Nicaragua 15
TT - Trinidad e Tobago 15
PA - Panama 14
SV - El Salvador 14
ET - Etiopia 13
GR - Grecia 13
AM - Armenia 12
BG - Bulgaria 12
KG - Kirghizistan 12
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
BB - Barbados 10
GE - Georgia 10
HU - Ungheria 10
RS - Serbia 10
CI - Costa d'Avorio 9
HR - Croazia 9
LV - Lettonia 9
MD - Moldavia 9
SN - Senegal 9
BH - Bahrain 8
BY - Bielorussia 8
GY - Guiana 8
MC - Monaco 8
NO - Norvegia 8
Totale 74.096
Salva come PNG Salva come JPEG
Città #
Dallas 6.253
Singapore 3.727
Ashburn 2.416
San Jose 2.367
Beijing 1.779
Chicago 1.477
Los Angeles 1.417
Hong Kong 1.332
Council Bluffs 926
Moscow 918
Ho Chi Minh City 844
Milan 813
New York 683
Salt Lake City 612
Chandler 562
Southend 543
Rome 536
Buffalo 534
Hanoi 508
Santa Clara 500
The Dalles 474
Fairfield 462
San Mateo 451
Dublin 446
Houston 416
São Paulo 369
Wilmington 362
Lauterbourg 360
Woodbridge 360
Hefei 354
Tampa 351
Helsinki 334
Seattle 324
Cambridge 322
Elk Grove Village 272
Boardman 264
North Bergen 244
Portsmouth 243
Falls Church 237
Munich 235
Pisa 226
Orem 218
Warsaw 217
Stevenage 215
Ann Arbor 212
Ottawa 211
Montreal 209
Florence 198
Beauharnois 193
Jacksonville 190
Brooklyn 177
Mexico City 168
Phoenix 165
London 164
Frankfurt am Main 161
Dearborn 156
Lawrence 155
Toronto 153
Istanbul 152
Tel Aviv 148
Tokyo 147
Denver 145
Sterling 133
Atlanta 130
Stockholm 130
Lancaster 129
Poplar 128
Chennai 126
Johannesburg 124
Amsterdam 123
Miami 120
Rio de Janeiro 119
Nuremberg 118
Dong Ket 117
Lappeenranta 107
Da Nang 106
Columbus 105
Figino 105
Naples 105
Bologna 104
Haiphong 99
Boston 96
Turin 88
Belo Horizonte 86
Dulles 79
Manchester 73
San Diego 73
Palermo 72
Biên Hòa 70
Turku 70
San Francisco 69
Washington 69
Genoa 67
Tashkent 66
Quito 65
Ankara 64
Charlotte 64
Mumbai 64
Detroit 63
Brasília 61
Totale 43.194
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.849
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.707
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.585
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 897
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 738
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 624
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 493
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 457
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 453
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 451
Echocardiographic and Cardiac Magnetic Resonance Imaging-Derived Strains in Relation to Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy 440
A simple echocardiographic score to rule out cardiac amyloidosis 394
A simple echocardiographic score to rule out cardiac amyloidosis 371
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 369
Building medical knowledge from real world registries: The case of heart failure 364
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 362
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 350
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 341
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 335
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 334
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 334
Treating chemoreflex in heart failure: modulation or demolition? 328
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 322
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 320
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 319
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 316
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 311
Eligibility for vericiguat in a real‐world, contemporary heart failure population 307
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 306
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 306
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 304
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 303
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 303
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 301
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 300
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 300
[Ten perspectives for research and innovation in cardiac amyloidosis] 299
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 297
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
Screening the health status of people working in a university 296
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 293
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 291
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 289
How to take arms against central apneas in heart failure 289
Sex-related differences in chronic heart failure 284
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 281
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 278
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 278
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 277
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 276
RNA-targeting and gene editing therapies for transthyretin amyloidosis 275
Cardiac light-chain deposition disease relapsing in the transplanted heart 274
Unmet needs in end-of-life care for heart failure patients 271
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 268
Atrial amyloidosis: mechanisms and clinical manifestations 268
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 267
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 267
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 267
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 265
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 264
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 262
Valve disease in cardiac amyloidosis: an echocardiographic score 261
Biomarkers for the diagnosis and management of heart failure: New frontiers 260
null 258
Disease features and management of cardiomyopathies in women 258
null 258
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 257
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 254
null 253
Biomarkers for the diagnosis and management of heart failure 253
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 251
Assessing cardiac mechanics through left ventricular haemodynamic forces 249
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 249
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 249
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 247
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 247
Cardiac magnetic resonance in patients with muscular dystrophies 247
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 245
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 244
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 243
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 243
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 242
Role of Imaging in Cardiomyopathies 241
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 241
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 241
Valvular heart disease in patients with cardiac amyloidosis 240
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 239
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 238
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 238
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 238
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 236
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 234
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 233
Cardiac troponins as biomarkers for cardiac disease 233
Cardiovascular disease and COVID-19: les liaisons dangereuses 232
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 231
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 230
Perspectives in noninvasive imaging for chronic coronary syndromes 229
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 229
Totale 34.435
Salva come PNG Salva come JPEG
Categoria #
all - tutte 372.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 372.171
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.361 0 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.303 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.848
2025/202642.499 2.194 6.182 4.866 5.533 4.011 2.661 4.125 1.997 2.695 2.804 2.770 2.661
2026/20272.476 1.276 1.200 0 0 0 0 0 0 0 0 0 0
Totale 74.743